We have been practicing urology for 20+ years and have been frustrated with the treatment options for bedwetting in children. That’s why we came together, brain-stormed, invented and patented this ground-breaking new device.

Global Continence Inc. has developed a novel technology that intercepts a bedwetting (enuresis) episode with transcutaneous electrical nerve stimulation (TENS) methodology that overrides and curtails the episode with a neuromodulation signal. Our bedwetting device (SOLUU™) is a novel solution to bedwetting in children and will be extended to adult and geriatric care. Our bedwetting device is an improvement on current commercially available technologies that are sold over the counter (OTC) in that it rapidly mitigates the flow of urine. The benefits of the system include an effective training system that raises efficacy and lowers the training time while also limiting hygiene and psychological factors relating to bedwetting. SOLUU™ includes sensors, devices to deliver the therapy, supporting pads, Bluetooth connectivity, algorithms and user interface.

SOLUU™ is intended to transform current sensors and devices.  The device will be effective by intercepting a bedwetting episode with transcutaneous nerve stimulation (TENS) methodology that overrides and curtails the episode with a neuromodulation signal. The unit shall consist of portable electronic device capable of detecting the presence of urine through a specifically developed moisture sensor that will generate an electrical signal which provides external urethral sphincter muscle contraction inhibiting urination and alerting parents to the occurrence of the event.  The pad will accommodate and interconnect the bedwetting control device, the humidity sensor and the electrodes.  In addition, an application has been developed to run on a smartphone operating system (Android and/or iOS) with the ability to store and provide for a smartphone via Bluetooth interface, the history of events for examination by the child, caregivers, and healthcare providers accompanying the treatment.  Information will also be de-identified and used by Global Continence Inc. via our website interface for technological improvements and market analysis.

The benefits of SOLUU™ will have a significant impact in pediatric healthcare by delivering a new technology to prevent nighttime urinary incontinence.  The initial impact is the creation of a new principle for the treatment of NE, namely, “learning” by means of an alarm that sounds when the child urinates, combined with the contraction of the urethral muscles, which will stop the flow of urine.  We set up the first prototype and found that it was possible to integrate a humidity sensor, alarm and stimulator, which were validated in early clinical trials. SOLUU™ is the first bedwetting device to have Wi-FI and Bluetooth control by smartphone.

Dr. Van Batavia is an Assistant Professor in the Division of Urology (Department of Surgery) at the University of Pennsylvania and the Children’s Hospital of Philadelphia.  As a surgeon-scientist, Dr. Van Batavia spends half of his time performing basic science and translational research in neuro-urology and medical device development.  He is currently using state-of-the-art neuroscience techniques to decipher the brain-bladder neural pathways involved in volitional voiding and his work is supported by an NIH/NIDDK K08 grant.  He recently received the 2019 Urology Care Foundation Rising Star in Urology Research Award and 2018 Diokno-Lapides Essay Contest Grand Prize.

Over the past 4 years, his research has been funded by grants from CHOP, the NIH, and the FDA (through the Philadelphia Pediatric Medical Device Consortium).  He is also a co-inventor on a provisional patent for a urological device which was developed through the BioStrategy Partners-Amp Tech Germinator Program.  He has published over 50 peer-reviewed articles and authored 10 book chapters on urologic topics.  

Dr. Van Batavia holds several leadership roles.  He is currently the Co-Chair of the Membership Committee of the American Academy of Pediatrics (AAP) Section on Urology (SOU) and co-editor of the section’s biannual newsletter.  He formerly served as the Fellow representative to the AAP SOU and Pediatric Urology Coordinating Council, and as a member of the Pediatric Urology Advisory Council to the American Board of Urology.  

 Dr. Van Batavia received his bachelor’s degree in molecular biophysics and biochemistry from Yale University and his Doctor of Medicine from Columbia University in New York City. He completed his general surgery internship and urology residency at Colombia University Medical Center/New York - Presbyterian Hospital and received the Mitchell C. Benson Resident Research Award at graduation in 2015.  He completed his fellowship in pediatric urology at the Children’s Hospital of Philadelphia and was supported by a Urology Care Foundation (UCF) Research Scholar Award and received the 2017 Outstanding Graduate Scholar Award from the UCF.  Dr. Van Batavia is currently completing his Master of Science in Translational Research from the University of Pennsylvania and has taken Medical Device and Healthcare Entrepreneurial classes at the Wharton School. 

Dr. Cristian Sager graduated from the Faculty of Medical Sciences, National University of Rosario, Argentina in 1998. From 1992 to 1999 he served as Assistant to the Chair of Histology and Embryology. He completed his residency and Head of Residency in Urology at Hospital Universitario Centenario de Rosario, Argentina in 2003. In 2001 he served an internship in Urology at Fundación Puigvert, Barcelona, Spain.

He began his career in Pediatric Urology attending the Victor J Vilela Children's Hospital in Rosario, Argentina from 2000 to 2003. Dr. Sager completed his training as a Pediatric Urologist at Prof. Dr. JP Garrahan Pediatric Hospital in Buenos Aires Argentina (2004-2006) where he received his career development and training in the Urodynamic and Bladder Dysfunctions Unit. Dr Sager was awarded a Basic Urology Research Grant and Best Research Paper Award in 2006.

He is a member of the spina bifida and Transition in Urology interdisciplinary team. He was Coordinator of the Pediatric Urology Group of the Argentine Society of Urology from 2018 to 2020. Additionally He has developed and organized five editions of the National Pediatric Urology Conference at Garrahan Hospital.

Dr. Sager has published paper and articles in national and international journals. He actively participates in the Argentine Society of Urology, the Argentine Society of Pediatrics, the Ibero-American Society of Pediatric Urology and CAU.

He is currently completing his training in statistics and clinical effectiveness at the University of Buenos Aires, Argentina.

Dr. José Murillo B. Netto did his initial medical training at the Faculdade de Medicina de Barbacena (FAME-FUJOB), in Barbacena, Minas Gerais, Brazil, where he graduated in December 1992. He then completed his residence training in Urology at the Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (HCFMRP-USP), Ribeirão Preto, São Paulo, Brazil, and was an Observer Fellow at the Children’s Hospital of Alabama, at Birmingham, AL, USA (1998-1999). In 2001, Dr. Netto earned his PhD in Surgery/Urology at the Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (FMRP-USP). During the years of 2018-2019, Dr. Netto work as a Visiting Professor at the Department of Urology of School of Medicine of Yale University, doing mostly research in bladder function and incontinence in children.

Dr. José Murillo B. Netto is a Full Professor at the Department of Surgery, Division of Urology, at the Universidade Federal de Juiz de Fora (UFJF), Juiz de Fora, Minas Gerais, Brazil, since 2004 and is the Chief of Pediatric Urology at the University Hospital of the Universidade Federal de Juiz de Fora (HU-UFJF). He is also an Associate Professor of Surgery at the Faculdade de Ciências Médicas e da Saúde de Juiz de Fora (SUPREMA). At the Universidade Federal de Juiz de Fora, Dr. Netto is also a Professor in the PhD program (Programa de Pós-Graduação em Saúde – PPGS) and the coordinator of the Interdisciplinary Group of Research in Urology (NIPU), where he supervises physicians, physiotherapists, psychologists and nurses in their Master and PhD studies and theses. He is the head of the Lower Urinary Tract Dysfunction, Neurogenic Bladder and Enuresis Clinics, coordinating a multi professional team consisting of physicians, physiotherapists, psychologists and nurses, as well as, post-graduating and graduating students.

Dr. Netto is a former Chief of the Department of Pediatric Urology of the Sociedade Brasileira de Urologia (SBU) e is the current Chief of the Department of Pediatric Urology at the Section of Minas Gerais of the Sociedade Brasileira de Urologia (SBU). He is a corresponding member of the American Urological Association (AUA), a member of the International Children’s Continence Society (ICCS), of the Sociedad Iberoamericana de Urologia Pediatrica (SIUP).

Dr. Netto has published about a 100 studies and book chapters in pediatric urology, being most of them related to enuresis and lower urinary tract symptoms. He holds a grant from the Brazilian National Council for Scientific and Technological Development (CNPQ) and has received other grants from the Fundação de Apoio a Pesquisa do Estado de Minas Gerais (FAPEMIG), and from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES).

Dr. José Murillo B. Netto has lectured extensively in Brazil and around the world, receiving research awards in Japan, USA, Spain and Brazil.

Dr. Susan Kirsch granulated from Union College and completed medical school at Downstate Medical College in Brooklyn, New York. She completed an internship in Medicine at Cornell’s New York Hospital in New York City and completed her residency in Psychiatry at Emory University School of Medicine in Atlanta. She then completed a fellowship in Child and Adolescent Psychiatry at Emory. Dr. Kirsch is a Board-Certified Child, Adolescent, and Adult Psychiatrist. She is a member of the American Academy of Psychiatry, American Academy of Child and Adolescent Psychiatry, and the Georgia Psychiatric Physicians Association. She is clinical assistant professor at Emory University School of Medicine. Dr. Kirsch practices in Atlanta, GA

Mr. Katz is the President and Chief Investment Officer of Matrix Asset Advisor, a New Yok Based Investment Management firm that he founded in 1986. He has overall responsibility for the firm’s investment efforts and serves on the Boards of two publicly traded mutual funds (Matrix Advisors Value Fund and the Matrix Advisors Dividend Fund)

 He graduated summa cum laude from Union College with a Bachelor of Arts degree in Economics. He received a Master of Business Administration degree, with a concentration in Finance, from New York University Graduate School of Business in 1987, graduating with distinction. Mr. Katz is a CFA charterholder. 

 After initially working at Management Asset Corporation (Westport, CT), Mr. Katz co-founded Value Matrix Management with the late John M. Gates in 1986. He served as the firm’s Senior Vice President and Chief Investment Officer and was Head of the Investment Policy Committee. In 1990, he merged Value Matrix Management organization into Matrix Asset Advisors. Mr. Katz chairs the Investment Policy Committee and is a Portfolio Manager/Analyst. 

 He appears frequently as a guest on CNBC and Bloomberg Radio.

Dr. Göran Läckgren is a Professor of Pediatric Urology at the University Children´s Hospital, Uppsala, Sweden. He graduated from the University of Uppsala where he had his training as a pediatric surgeon and urologist. He became the head of the section of Pediatric Urology in 1986. He was one of the founders of the Swedish Enuresis Academy (SEA) and was the President from 1993 until 2008 and is still an active member of the Board. He has been the main organizer of the first congress of ICCS (International Children’s Continence Society) in
1997 in Paris and main organizer of the Second joint Congress of AAP and ESPU in 2005 in Uppsala.

Dr Läckgren has been a member of the board of the European Society for Pediatric Urology and has acted as Treasurer and later as the President of the society. He was appointed Honorary Member of the ESPU in 2015. Dr Läckgren is a member of the Society for Pediatric Urology Surgeons (SPUS) an international member of the American Association of Genito Urinary Surgeons (AAGUS). Dr Läckgren was appointed the first Professor of Pediatric Urology at the University of Uppsala in 2005. His main scientific interest has been on the function of the undescended testis; Vesicoureteral Reflux-particularly endoscopic treatment; Enuresis and urinary incontinence; Dr Läckgren published over 130 articles and book-chapters in Pediatric Urology. He has been a visiting professor and lecturer to more than 40 countries all over the world particularly on the topics of Endoscopic treatment of Vesicoureteral Reflux and on Nocturnal Enuresis.

Dr. Renea Sturm is an Assistant Professor of Pediatric Urology at University of California, Los Angeles (UCLA). She is a physician-scientist leading bench to bedside research in surgical innovation, including multi-disciplinary collaborative work that applies novel biomaterials to tissue engineering and reconstructive surgery. The primary aim of her research is to apply basic science and technological advancements to improve equity, quality, and consistency in urologic surgery regardless of surgeon experience or care setting. Dr. Sturm was recently recognized as a 2022 Outstanding Graduate Scholar by the American Urological Association/Urology Care Foundation (AUA/UCF) for her 2-year project that developed highly elastic biomaterials for urinary tract applications. Her research is supported by grants from the National Science Foundation, the Technology Development Group at UCLA, the UCLA Clinical and Translational Sciences Institute, and the AUA/UCF. Dr. Sturm’s clinical practice includes pediatric reconstructive minimally invasive and endoscopic surgery, complex hypospadias repair, and lower urinary tract conditions including nocturnal enuresis.

Dr. Tiago Rosito is Professor and Chairman of Urology at Universidade Federal do Rio Grande do Sul, the largest academic unit in south Brazil and one of the largest in South America. He earned his medical degree from Universidade Federal do Rio Grande do Sul Medical School in Porto Alegre, Brazil. He completed both residency in general surgery and Urology at Hospital de Clínicas de Porto Alegre. He then completed his fellowship and PhD in Pediatric Urology at Hospital São Paulo in São Paulo, Brazil. Returning to Porto Alegre he completed a new fellowship in reconstructive urology and a master's degree in surgical science. Since then, he is the Director of Pediatric and Reconstructive Urology at Hospital de Clínicas de Porto Alegre.

Dr. Rosito is the first Secretary of the Brazilian School of Pediatric Urology, treasurer of Iberoamerican Society of Pediatric Urology, and Chief of Pediatric Urology Section of Brazilian Society of Pediatric Urology. Dr Rosito is member of most of the Pediatric Urology Societies internationally. He has published more than 50 journal articles and book chapters in the field. Dr. Rosito was an invited surgeon and Professor in many international congresses and Hospitals in Latin America.

Mr. Leandro Mattos graduated in Mechatronics from the SENAI CIMATEC School in Salvador-BA, Brazil (2017). After graduation, he played a crucial role in the development of machinery to produce sustainable branded products using recyclable materials. Mr. Mattos worked in the development of complex equipment and machinery, including the development of robotic devices at the AREA 1 faculty, for the great robot combat (Extreme Cyber ​​Fight), with participation of faculties from around the world.

In 2016, Mr. Mattos founded Prottec. He partnered with the company Solares Automação to develop devices for industrial solutions, such as the security system for controlling the productivity of automotive parts in the Jeep Renegade and Jeep Compass lines, as well as the production of engines in the Ford EcoSport line. Prottec expanded its lines of action by providing services in partnership with the Dream Group, offering consulting, lectures, seminars, and professional growth by Dreamalltec, as well as solutions in electronic repairs and industrial application development by Dreamation. Mr. Mattos worked to create and implement the technological systems of the Armed Forces of the Brazilian Navy, including automated tracking systems for vessels and submarines. In 2019, Mr. Mattos, also an expert in TENS technology, was invited to participate in Global Continence, Inc. to develop Soluu™ for the treatment of nocturnal enuresis.

Dr. Barajas is a healthcare professional with over 15 years of experience in Clinical Research in Latin-American, Europe, and US.  Since June 2021 she was appointed as Regional Operations Head for LATAM in Merck & Co., ensuring the oversight of the clinical trials along the region as well as being the POC for to the rest of the functional areas both Globally and within LATAM.

Before her current role she was the Clinical Research Director for Mexico MSD running more than 60 clinical trials in different therapeutic areas with focus on oncology, infectious diseases, primary care, and vaccines.

Through her career she has had the opportunity to work in different pharmaceutical companies with specialized responsibilities and involved in global projects such as Study Budget Center of Excellence, Risk Based Monitoring, Monitoring Excellence, Neoadjuvant Clinical Trials, and electronic Trial Master File (eTMF).

She holds a Master’s in Science with focus in clinical research, as well as a certification as a Black Belt Lean Six Sigma, which have supported and enhanced her career and thus implementing continuous improvement for the standard operating procedures such as cycle times, training, and eTMF.

Dr. Bujons is a Pediatric Urologic Surgeon specializing in the treatment of bladder exstrophy, spina bifida, sexual development anomalies (DSD) and pediatric lithiasis through minimally invasive surgery techniques such as laparoscopy, robotics and endourology with flexible instruments and lasers.

She obtained her degree in Medicine and Surgery from the University of Barcelona (UB) and then completed her Urology Residency at Fundació Puigvert. She has a PhD in Sexuality in Spina Bifida from the Autonomous University of Barcelona (UAB) and an Executive Master in Healthcare Organizations Leadership (EMDOS) from Esade. In 2008 she joined the Urology Department of Fundació Puigvert where she currently holds the position of Head of the Division of Pediatric Urology.

Dr. Bujons has authored numerous scientific papers, book chapters and several videos on surgical techniques. She has more than 200 papers presented in conferences and scientific meetings, some of them awarded, participating as well as guest lecturer in many of them. She has also been involved in the organization of several courses, congresses and scientific meetings and has worked in many research works throughout his career.

She is Associate Professor at the Faculty of Medicine of the Autonomous University of Barcelona (UAB) and is Professor of the Master in Pediatric Urology at the International University of Andalusia (UNIA).

Dr. Bujons is Fellow of the European Academy of Pediatric Urology (FEAPU), Vice President of the Sociedad Iberoamericana de Urología Pediátrica (SIUP), member of the Educational Committee of the European Society of Pediatric Urology (ESPU), associate member of the EAU Section of Uro-Technology (ESUT), Board Member of the EAU Working Group on Paediatric Urology (EWPU), Ex-Officio EWPU Board Member of the EAU Section of Urolithiasis (EULIS) and serves as reviewer for the Britihs Journal of Urology, the Journal of Pediatric Urology, Actas Españolas de Urología and Archivos Españoles de Urología.

Global Center for Medical Innovation

We accelerate the development, testing, training and commercialization of innovative medical products that improve quality based outcomes and delivery of healthcare for patients.

GCMI

575 14th St NW
Atlanta, GA 30318

BMR Medical S.A

First, the patient. We work with passion and integrity, innovating to care for people alongside health professionals. We are committed to excellence and sustainability. We believe that together we can make treatments safer.

BR 116, km 1.4, no. 1440
Campina Grande do Sul
83430-000 - Paraná - Brazil
+55 41 3093-3900